Skip to main content

Table 2 Prevalence of colonization of MDR bacteria in newly-hospitalized patients (N = 487) stratified by the specific MDR bacteria and by the specimen collection site

From: A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital

MDR bacteria All sites, n (%) Nasal cavity, n (%) Throat, n (%) Inguinal area, n (%) Rectum, n (%)
ESBL-producing Enterobacteriaceae 254 (52.2%) 13 (2.7%) 42 (8.6%) 80 (16.4%) 232 (47.6%)
E. coli 206 (42.3%) 5 (1.0%) 14 (2.9%) 58 (11.9%) 189 (38.8%)
K. pneumoniae 81 (16.6%) 9 (1.8%) 31 (6.4%) 29 (6.0%) 60 (12.3%)
 Other Enterobacteriaceae 8 (1.6%) 0 1 (0.2%) 3 (0.6%) 7 (1.4%)
A. baumannii
 Carbapenem-susceptible 88 (18.0%) 13 (2.7%) 43 (8.8%) 34 (7.0%) 32 (6.6%)
 Carbapenem-resistant 63 (12.9%) 13 (2.7%) 16 (3.3%) 32 (6.6%) 28 (5.8%)
P. aeruginosa
 Carbapenem-susceptible 33 (6.8%) 10 (2.1%) 11 (2.3%) 18 (3.7%) 12 (2.5%)
 Carbapenem-resistant 23 (4.7%) 9 (1.9%) 18 (3.7%) 2 (0.4%) 6 (1.2%)
Staphylococcus aureus
 Methicillin-susceptible 49 (10.0%) 29 (6.0%) 21 (4.3%) 8 (1.6%) 11 (2.3%)
 Methicillin-resistant 35 (7.2%) 21 (4.3%) 17 (3.5%) 6 (1.2%) 12 (2.5%)